These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 6284681

  • 1. The role of nuclear scanning in head and neck surgery.
    Pretorius D, Taylor A.
    Head Neck Surg; 1982; 4(5):427-32. PubMed ID: 6284681
    [Abstract] [Full Text] [Related]

  • 2. Nuclear medicine in diagnosis and treatment of diseases of the head and neck. I. Salivary and parathyroid gland disease and one identification and staging of head and neck tumors.
    Blahd WH, Rose JG.
    Head Neck Surg; 1981; 4(2):129-35. PubMed ID: 6273364
    [Abstract] [Full Text] [Related]

  • 3. Nuclear medicine in diagnosis and treatment of diseases of the head and neck: II.
    Blahd WH, Rose JG.
    Head Neck Surg; 1982; 4(3):213-26. PubMed ID: 7040309
    [Abstract] [Full Text] [Related]

  • 4. Contribution of nuclear medicine to the diagnosis and management of extracranial head and neck diseases (excluding thyroid and parathyroid).
    Chisin R, Noyek AM, Israel O, Witterick IJ, Front D, Kirsh JC.
    Isr J Med Sci; 1992; 28(3-4):254-61. PubMed ID: 1592597
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Possible explanation of appearance of Warthin's tumor on I-123 and Tc-99m-pertechnetate scans.
    Siddiqui AR, Weisberger EC.
    Clin Nucl Med; 1981 Jun; 6(6):258-60. PubMed ID: 6262003
    [Abstract] [Full Text] [Related]

  • 8. Radionuclide salivary scanning.
    Greyson ND, Noyek AM.
    J Otolaryngol Suppl; 1982 Aug; 10():1-47. PubMed ID: 6292444
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of pertechnetate and radioiodine thyroid scintiscans in thyroid disease.
    Reschini E, Catania A, Ferrari C, Bergonzi M, Paracchi A, Raineri P.
    J Nucl Biol Med (1991); 1993 Mar; 37(1):12-7. PubMed ID: 8392382
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preoperative scintigraphic detection of cervical metastases from thyroid carcinoma with technetium-99m pertechnetate.
    Vieras F.
    Clin Nucl Med; 1985 Aug; 10(8):567-9. PubMed ID: 2994934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report.
    Lamberigts G, De Roo M, Devos P, Burie D.
    Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of technetium--99m uptake studies in the rapid assessment of thyroid function.
    Ogunleye OT, Ohwovoriole AE, Campbell OB.
    East Afr Med J; 1986 Sep; 63(9):571-6. PubMed ID: 3024951
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 99Tc(m)-MIBI scanning of the thyroid gland in patients with markedly decreased pertechnetate uptake.
    Alonso O, Mut F, Lago G, Aznarez A, Núñez M, Cánepa J, Touya E.
    Nucl Med Commun; 1998 Mar; 19(3):257-61. PubMed ID: 9625501
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.